Back to search results
NCT07517692

Facilitation of Information eXchange for Shared Decision Making for Lung Cancer Screening

Enrolling by Invitation
NAAges 50–77InterventionalScreening
University of Massachusetts, Worcester
~120 participants
Updated 2026-05-14 on ClinicalTrials.gov
What's tested:FIX-SDMUsual Care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Completion of Lung Cancer Screening (LCS) within 3 months
Measured over 3 months after the index visit

Conditions

Lung Cancer Screening

Explore related trials

Lung Carcinoma

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Mayuko Ito Fukunaga, MD, MSc · PRINCIPAL_INVESTIGATOR · UMass Chan Medical School

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

PCPs (physicians or advanced practitioners)
Who practice in general internal medicine or family medicine clinics in UMass Memorial Health
Adults between the ages of 50 and 77
Meets criteria for Lung Cancer Screening (LCS) (Current eligibility includes: An individual who currently smokes or quit smoking within 15 years with at least a 20 pack-year smoking history)
Has a smartphone with texting capability
English-speaking
Has a scheduled PCP visit in the next \~3-6 weeks from study enrollment with one of the PCP participants enrolled in the study

Exclusion

Participation in the previous study to co-develop the provider intervention (to avoid bias)
Prior LCS
Chest CT within the last 12 months
History of lung cancer
Active cancer requiring treatment
Supplemental oxygen use
Pregnancy
Participation in the previous study to co-develop the patient intervention (to avoid bias)

What this trial measures

  • Completion of Lung Cancer Screening (LCS) within 3 months3 months after the index visit

    The proportion of patients in each arm who completed LCS within 3 months of the index primary care visit